Back to Search Start Over

Identification and Functional Characterization of Metabolites for Bone Mass in Peri- and Postmenopausal Chinese Women

Authors :
Hong-Wen Deng
Xia-Fang Wang
Rui Gong
Jun-Min Lu
Feng-Ye Lyu
Qiang Zhang
Yin-Hua Zhang
Zhang-Fang Li
Jie Shen
Xu Lin
Qi Zhao
Marco Brotto
Yating Du
Yuan-Cheng Chen
Zhi Chen
Chenglin Mo
Yu-Qian Song
Dao-Yan Pan
Hong-Mei Xiao
Martin R. Schiller
Cheng Peng
Hui Shen
Qing Tian
Hui-Min Liu
Christopher J. Papasian
Kuan-Jui Su
Rou Zhou
Zeng-Xin Ao
Chan-Yan Weng
Shi-di Hu
Source :
J Clin Endocrinol Metab
Publication Year :
2021
Publisher :
Oxford University Press, 2021.

Abstract

Context Although metabolic profiles appear to play an important role in menopausal bone loss, the functional mechanisms by which metabolites influence bone mineral density (BMD) during menopause are largely unknown. Objective We aimed to systematically identify metabolites associated with BMD variation and their potential functional mechanisms in peri- and postmenopausal women. Design and Methods We performed serum metabolomic profiling and whole-genome sequencing for 517 perimenopausal (16%) and early postmenopausal (84%) women aged 41 to 64 years in this cross-sectional study. Partial least squares regression and general linear regression analysis were applied to identify BMD-associated metabolites, and weighted gene co-expression network analysis was performed to construct co-functional metabolite modules. Furthermore, we performed Mendelian randomization analysis to identify causal relationships between BMD-associated metabolites and BMD variation. Finally, we explored the effects of a novel prominent BMD-associated metabolite on bone metabolism through both in vivo/in vitro experiments. Results Twenty metabolites and a co-functional metabolite module (consisting of fatty acids) were significantly associated with BMD variation. We found dodecanoic acid (DA), within the identified module causally decreased total hip BMD. Subsequently, the in vivo experiments might support that dietary supplementation with DA could promote bone loss, as well as increase the osteoblast and osteoclast numbers in normal/ovariectomized mice. Dodecanoic acid treatment differentially promoted osteoblast and osteoclast differentiation, especially for osteoclast differentiation at higher concentrations in vitro (eg,10, 100 μM). Conclusions This study sheds light on metabolomic profiles associated with postmenopausal osteoporosis risk, highlighting the potential importance of fatty acids, as exemplified by DA, in regulating BMD.

Details

Language :
English
Database :
OpenAIRE
Journal :
J Clin Endocrinol Metab
Accession number :
edsair.doi.dedup.....3aab6b512e77c84ee4d81c74670fd4e3